Cargando…

CSF Neurofilament Light Chain but not FLT3 Ligand Discriminates Parkinsonian Disorders

The differentiation between multiple system atrophy (MSA) and Parkinson’s disease (PD) is difficult, particularly in early disease stages. Therefore, we aimed to evaluate the diagnostic value of neurofilament light chain (NFL), fms-like tyrosine kinase ligand (FLT3L), and total tau protein (t-tau) i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Herbert, Megan K., Aerts, Marjolein B., Beenes, Marijke, Norgren, Niklas, Esselink, Rianne A. J., Bloem, Bastiaan R., Kuiperij, H. Bea, Verbeek, Marcel M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2015
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4419719/ https://www.ncbi.nlm.nih.gov/pubmed/25999911 http://dx.doi.org/10.3389/fneur.2015.00091

Ejemplares similares

Cerebrospinal Fluid Galectin-1 Levels Discriminate Patients with Parkinsonism from Controls
por: Marques, Tainá M., et al.
Publicado: (2018)

MicroRNAs in Cerebrospinal Fluid as Potential Biomarkers for Parkinson’s Disease and Multiple System Atrophy
por: Marques, Tainá M., et al.
Publicado: (2016)

Cerebrospinal fluid monocyte chemoattractant protein 1 correlates with progression of Parkinson’s disease
por: Santaella, Anna, et al.
Publicado: (2020)

Inflammation biomarker discovery in Parkinson’s disease and atypical parkinsonisms
por: Santaella, Anna, et al.
Publicado: (2020)

Factors associated with mortality in early stages of parkinsonism
por: van Rumund, Anouke, et al.
Publicado: (2022)

Parkinson’s Disease Diagnostic Observations (PADDO): study rationale and design of a prospective cohort study for early differentiation of parkinsonism
por: van Rumund, Anouke, et al.
Publicado: (2018)

Identification of cerebrospinal fluid biomarkers for parkinsonism using a proteomics approach
por: Marques, Tainá M., et al.
Publicado: (2021)

Neurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MS
por: Bergman, Joakim, et al.
Publicado: (2016)

Conventional 3T brain MRI and diffusion tensor imaging in the diagnostic workup of early stage parkinsonism
por: Meijer, Frederick J. A., et al.
Publicado: (2015)

Trait Impulsivity Is Associated with the Risk of Falls in Parkinson’s Disease
por: Smulders, Katrijn, et al.
Publicado: (2014)

Contribution of routine brain MRI to the differential diagnosis of parkinsonism: a 3-year prospective follow-up study
por: Meijer, Frederick J. A., et al.
Publicado: (2011)

α‐Synuclein real‐time quaking‐induced conversion in the cerebrospinal fluid of uncertain cases of parkinsonism
por: van Rumund, Anouke, et al.
Publicado: (2019)

CSF or serum neurofilament light added to α‐Synuclein panel discriminates Parkinson's from controls
por: Oosterveld, Linda P., et al.
Publicado: (2019)

A multifunctional ELISA to measure oxidised proteins: oxPin1 in Alzheimer's brain as an example
por: Herbert, Megan K., et al.
Publicado: (2015)

A LRSAM1 mutation links Charcot–Marie–Tooth type 2 to Parkinson's disease
por: Aerts, Marjolein B., et al.
Publicado: (2015)

Clinical Application of Brain MRI in the Diagnostic Work-up of Parkinsonism
por: Meijer, Frederick J.A., et al.
Publicado: (2017)

CSF Heavy Neurofilament May Discriminate and Predict Motor Neuron Diseases with Upper Motor Neuron Involvement
por: Simonini, Cecilia, et al.
Publicado: (2021)

Cerebral causes and consequences of parkinsonian resting tremor: a tale of two circuits?
por: Helmich, Rick C., et al.
Publicado: (2012)

Proteomic profiling of striatal tissue of a rat model of Parkinson's disease after implantation of collagen‐encapsulated human umbilical cord mesenchymal stem cells
por: Santaella, Anna, et al.
Publicado: (2020)

Quantitative susceptibility mapping and blood neurofilament light chain differentiate between parkinsonian disorders
por: Zhang, Piao, et al.
Publicado: (2022)

Is CSF neurofilament light chain measurement relevant for MS?
por: Matsui, Makoto
Publicado: (2020)

Letter to the Editor on “A Randomized, Controlled Trial of Exercise for Parkinsonian Individuals With Freezing of Gait”
por: Nonnekes, Jorik, et al.
Publicado: (2020)

Peripheral decarboxylase inhibitors paradoxically induce aromatic L-amino acid decarboxylase
por: van Rumund, Anouke, et al.
Publicado: (2021)

The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias
por: Abu-Rumeileh, Samir, et al.
Publicado: (2018)

Serum neurofilament light protein predicts clinical outcome in traumatic brain injury
por: Shahim, Pashtun, et al.
Publicado: (2016)

Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder
por: Hansson, Oskar, et al.
Publicado: (2017)

Assessment of dual tasking has no clinical value for fall prediction in Parkinson’s disease
por: Smulders, Katrijn, et al.
Publicado: (2012)

Levels and Age Dependency of Neurofilament Light and Glial Fibrillary Acidic Protein in Healthy Individuals and Their Relation to the Brain Parenchymal Fraction
por: Vågberg, Mattias, et al.
Publicado: (2015)

CSF neurofilament light chain reflects corticospinal tract degeneration in ALS
por: Menke, Ricarda A L, et al.
Publicado: (2015)

Neurofilaments in blood and CSF for diagnosis and prediction of onset in Creutzfeldt-Jakob disease
por: Steinacker, Petra, et al.
Publicado: (2016)

Plasma and CSF neurofilament light: Relation to longitudinal neuroimaging and cognitive measures
por: Mielke, Michelle M., et al.
Publicado: (2019)

CSF Neurofilament Light Chain Elevation Predicts ALS Severity and Progression
por: Sun, Qionghua, et al.
Publicado: (2020)

Combination of serum and CSF neurofilament-light and neuroinflammatory biomarkers to evaluate ALS
por: Brodovitch, Alexandre, et al.
Publicado: (2021)

CSF Neurofilament Light Chain Concentrations Predict Outcome in Bacterial Meningitis
por: Chekrouni, Nora, et al.
Publicado: (2021)

Neurofilament light (NfL) as biomarker in serum and CSF in status epilepticus
por: Margraf, Nils G., et al.
Publicado: (2023)

Nigrosome-1 on Susceptibility Weighted Imaging to Differentiate Parkinson’s Disease From Atypical Parkinsonism: An In Vivo and Ex Vivo Pilot Study
por: Meijer, Frederick J.A., et al.
Publicado: (2016)

Elevated neurofilament light chain CSF/serum ratio indicates impaired CSF outflow in idiopathic intracranial hypertension
por: Engel, Sinah, et al.
Publicado: (2023)

Translating Evidence to Advanced Parkinson's Disease Patients: A Systematic Review and Meta‐Analysis
por: Nijhuis, Frouke A.P., et al.
Publicado: (2021)

CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome
por: Khalil, M, et al.
Publicado: (2013)

Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis
por: Kuhle, Jens, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_cb54h3l02armk8n4neglutpd8p